Prescription Required
April 2, 2025 by Marilyn B. (Illinois, United States)
“Fine”
Please be aware that all information shared here at Canada Pharmacy has been medically reviewed and fact-checked for accuracy. These verifications are made by board-certified medical professionals who have the authority required to state that information related to medical conditions, symptoms, procedures and tests, and standard treatment protocols is valid and truthful. This is based on current guidelines and consensuses shared amongst medical professionals, and in representation of the latest research.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.
Your dermatologist or primary care provider may prescribe Eucrisa (crisaborole), a topical prescription medication designed to treat mild to moderate atopic dermatitis in pediatric and adult patients.
Atopic dermatitis is also referred to as eczema. Common symptoms may include itching, inflamed skin, redness, dry or scaly skin, blisters or oozing lesions, thickening skin, crusting, hyperpigmentation, papules, and sleep disturbances.
Belonging to the non-steroidal phosphodiesterase 4 (PDE-4) inhibitors class, the active ingredient increases cyclic adenosine monophosphate (cAMP) levels. This action reduces the immune response and subsequent inflammation, offering relief from symptoms associated with eczema.
|
Fact Table |
|
|
Formula |
C14H10BNO3 |
|
License |
US FDA |
|
Bioavailability |
Low systemic absorption (topical use) |
|
Legal status |
Prescription only (Rx) |
|
Chemical Name |
(4-[(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy]benzyl alcohol) |
|
Elimination half-life |
~2 hours (metabolite) |
|
Dosage (Strength) |
2% topical ointment |
|
Pregnancy |
Consult a doctor |
|
Brands |
Eucrisa |
|
Protein binding |
97% |
|
PubChem CID |
16721649 |
|
MedlinePlus |
a617040 |
|
ChEBI |
CHEBI:82720 |
|
ATC code |
D11AH04 |
|
DrugBank |
DB04984 |
|
KEGG |
D09730 |
|
Routes of administration |
Topical |
Apply a thin layer of Eucrisa to the affected area(s) twice daily.
Do not use this product for longer than prescribed by your doctor.
Eucrisa is intended for external use only and should not come into contact with the eyes, ears, nose, vagina, or other mucous membranes.
Following each application, thorough handwashing is recommended, and caution should be exercised to avoid contact with sensitive areas.
The active ingredient in Eucrisa is crisaborole. Additionally, the formulation includes the following inactive ingredients:
Tell your doctor and other healthcare professionals if you have any history of allergic reactions to the above ingredients.
There are no significant drug-drug interactions between Eucrisa and other medications.
People prescribed Eucrisa should exercise caution and inform their healthcare provider of any pre-existing medical conditions, especially those related to skin infections or sensitivities.
Take Eucrisa exactly as your doctor prescribes, and do not change the dosage without consulting your physician.
Additionally, individuals with allergies to Eucrisa or its inactive ingredients should refrain from using the drug. Hypersensitivity reactions at the application site may occur, including redness, swelling, itching, hives, and difficulty breathing.
Those with a history of kidney problems should inform their doctor, as Eucrisa is primarily metabolized by the kidneys.
Common side effects of this drug can include:
Eucrisa [package insert]. New York, NY: Pfizer; March 2020.
